NO20071711L - Sammensetninger inneholdende piperacillin, tazobactam og en aminokarboksylsyre i et natriumlaktat fortynningsmiddel - Google Patents
Sammensetninger inneholdende piperacillin, tazobactam og en aminokarboksylsyre i et natriumlaktat fortynningsmiddelInfo
- Publication number
- NO20071711L NO20071711L NO20071711A NO20071711A NO20071711L NO 20071711 L NO20071711 L NO 20071711L NO 20071711 A NO20071711 A NO 20071711A NO 20071711 A NO20071711 A NO 20071711A NO 20071711 L NO20071711 L NO 20071711L
- Authority
- NO
- Norway
- Prior art keywords
- tazobactam
- sodium lactate
- carboxylic acid
- compositions containing
- amino carboxylic
- Prior art date
Links
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 title abstract 3
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 title abstract 3
- 239000003085 diluting agent Substances 0.000 title abstract 3
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 title abstract 3
- 229960002292 piperacillin Drugs 0.000 title abstract 3
- 229940005581 sodium lactate Drugs 0.000 title abstract 3
- 235000011088 sodium lactate Nutrition 0.000 title abstract 3
- 239000001540 sodium lactate Substances 0.000 title abstract 3
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 title abstract 3
- 229960003865 tazobactam Drugs 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61887204P | 2004-10-14 | 2004-10-14 | |
| US71917705P | 2005-09-22 | 2005-09-22 | |
| PCT/US2005/036938 WO2006044600A1 (en) | 2004-10-14 | 2005-10-12 | Compositions containing piperacillin, tazobactam and a aminocarboxilic acid in a sodium lactate diluent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20071711L true NO20071711L (no) | 2007-07-12 |
Family
ID=35520532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20071711A NO20071711L (no) | 2004-10-14 | 2007-03-30 | Sammensetninger inneholdende piperacillin, tazobactam og en aminokarboksylsyre i et natriumlaktat fortynningsmiddel |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060084639A1 (es) |
| EP (1) | EP1799209A1 (es) |
| JP (1) | JP2008516967A (es) |
| KR (1) | KR20070110256A (es) |
| AU (1) | AU2005295644A1 (es) |
| BR (1) | BRPI0516583A (es) |
| CA (1) | CA2581303A1 (es) |
| CR (1) | CR9056A (es) |
| EC (1) | ECSP077387A (es) |
| IL (1) | IL182354A0 (es) |
| MX (1) | MX2007004490A (es) |
| NO (1) | NO20071711L (es) |
| RU (1) | RU2007111484A (es) |
| WO (1) | WO2006044600A1 (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129382B (zh) * | 2006-08-25 | 2013-12-25 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和缓冲组分的抗生素复方 |
| ITMI20070568A1 (it) | 2007-03-22 | 2008-09-23 | Acs Dobfar Spa | Comosizione farmaceutica sterile iniettabile avente piperacillina sodica e tazobactam sodico come principi attivi |
| US20090075966A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched tazobactam |
| JP5639471B2 (ja) * | 2008-07-28 | 2014-12-10 | 惠三 山口 | 感染症治療効果増強剤 |
| UA115966C2 (uk) | 2010-11-25 | 2018-01-25 | Аллекра Серап'Ютікс Гмбх | ЗАСТОСУВАННЯ β-ЛАКТАМНИХ СПОЛУК ДЛЯ ЛІКУВАННЯ БАКТЕРІАЛЬНИХ ІНФЕКЦІЙ АБО ЗАПОБІГАННЯ ЦИМ ІНФЕКЦІЯМ |
| US20130065874A1 (en) | 2011-09-09 | 2013-03-14 | Cubist Pharmaceuticals, Inc. | Methods for treating intrapulmonary infections |
| WO2013042140A2 (en) * | 2011-09-23 | 2013-03-28 | Manu Chaudhary | Non antibiotic,non peptide compounds for antibiotic efficacy & safety enhancement |
| US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| CA2906151A1 (en) | 2013-03-15 | 2014-09-18 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| US20140274997A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Cephalosporin pharmaceutical compositions |
| WO2015035376A2 (en) | 2013-09-09 | 2015-03-12 | Calixa Therapeutics, Inc. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| WO2022106611A1 (en) * | 2020-11-20 | 2022-05-27 | Xellia Pharmaceuticals Aps | Novel compositions of beta-lactam compounds |
| WO2022106630A1 (en) * | 2020-11-20 | 2022-05-27 | Xellia Pharmaceuticals Aps | Stable formulations comprising piperacillin and/or tazobactam |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4562073A (en) * | 1982-12-24 | 1985-12-31 | Taiho Pharmaceutical Company Limited | Penicillin derivatives |
| US6207661B1 (en) * | 1999-02-22 | 2001-03-27 | Baxter International Inc. | Premixed formulation of piperacillin sodium and tazobactam sodium injection |
| US20020132220A1 (en) * | 2000-12-27 | 2002-09-19 | Berens Kurt L. | Use of selectin antagonists in organ preservation solutions |
| WO2003088914A2 (en) * | 2002-04-18 | 2003-10-30 | The University Of Iowa Research Foundation | Methods of inhibiting and treating bacterial biofilms by metal chelators |
| US20040120956A1 (en) * | 2002-06-27 | 2004-06-24 | Song Xiao-Yu R. | CNGH0004 polypeptides, antibodies, compositions, methods and uses |
| DE602004010862T2 (de) * | 2003-04-14 | 2009-01-02 | Wyeth Holdings Corp. | Zusammensetzungen enthaltend Piperacillin und Tazobactam zur Injektion |
| US6900184B2 (en) * | 2003-04-14 | 2005-05-31 | Wyeth Holdings Corporation | Compositions containing pipercillin and tazobactam useful for injection |
| AU2003230899A1 (en) * | 2003-04-14 | 2004-11-26 | Wyeth Holdings Corporation | Compositions containing piperacillin and tazobactam useful for injection |
-
2005
- 2005-10-12 BR BRPI0516583-0A patent/BRPI0516583A/pt not_active IP Right Cessation
- 2005-10-12 MX MX2007004490A patent/MX2007004490A/es unknown
- 2005-10-12 KR KR1020077010612A patent/KR20070110256A/ko not_active Application Discontinuation
- 2005-10-12 AU AU2005295644A patent/AU2005295644A1/en not_active Abandoned
- 2005-10-12 EP EP05807860A patent/EP1799209A1/en not_active Withdrawn
- 2005-10-12 CA CA002581303A patent/CA2581303A1/en not_active Abandoned
- 2005-10-12 RU RU2007111484/15A patent/RU2007111484A/ru not_active Application Discontinuation
- 2005-10-12 JP JP2007536916A patent/JP2008516967A/ja not_active Withdrawn
- 2005-10-12 WO PCT/US2005/036938 patent/WO2006044600A1/en active Application Filing
- 2005-10-14 US US11/250,716 patent/US20060084639A1/en not_active Abandoned
-
2007
- 2007-03-30 NO NO20071711A patent/NO20071711L/no not_active Application Discontinuation
- 2007-04-01 IL IL182354A patent/IL182354A0/en unknown
- 2007-04-11 EC EC2007007387A patent/ECSP077387A/es unknown
- 2007-04-13 CR CR9056A patent/CR9056A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1799209A1 (en) | 2007-06-27 |
| US20060084639A1 (en) | 2006-04-20 |
| BRPI0516583A (pt) | 2008-09-16 |
| CA2581303A1 (en) | 2006-04-27 |
| MX2007004490A (es) | 2007-05-08 |
| AU2005295644A1 (en) | 2006-04-27 |
| JP2008516967A (ja) | 2008-05-22 |
| ECSP077387A (es) | 2007-05-30 |
| KR20070110256A (ko) | 2007-11-16 |
| IL182354A0 (en) | 2007-09-20 |
| CR9056A (es) | 2007-09-07 |
| WO2006044600A1 (en) | 2006-04-27 |
| RU2007111484A (ru) | 2008-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071711L (no) | Sammensetninger inneholdende piperacillin, tazobactam og en aminokarboksylsyre i et natriumlaktat fortynningsmiddel | |
| PH12013502449A1 (en) | Novel method for preventing or treating m tuberculosis infection | |
| NO20060416L (no) | Ny anvendelse I | |
| CO5700796A2 (es) | Composiciones que contienen piperacilina y tazobactam utiles para inyecciones | |
| WO2006050303A3 (en) | Intravaginal treatment of vaginal infections with metronidazole compositions | |
| BRPI0411241A (pt) | agentes terapêuticos úteis para o tratamento de dor | |
| BRPI0519195A2 (pt) | composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal | |
| EP2349279A4 (en) | ALDEHYDE DEHYDROGENASE MODULATORS AND METHOD OF USE THEREOF | |
| NO20062513L (no) | Sammensetninger og doseringsformer for forsterket absorpsjon av metformin | |
| BR0210971A (pt) | Formas inovadoras de dosagem de benzimidazol substituìdo e método para usar as mesmas | |
| NO20042596L (no) | Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1 | |
| ATE538774T1 (de) | Pharmazeutische formulierungen und verfahren zur behandlung von atemwegsinfektionen | |
| DK1317419T3 (da) | Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler | |
| WO2004027020A3 (en) | Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis | |
| ATE337712T1 (de) | Zusammensetzung zur intestinalen verabreichung | |
| EE200400031A (et) | Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat | |
| UY26474A1 (es) | Inhibidores de aminotransferasa dependiente de aminoácidos de cadena ramificada, y su uso en el tratamiento de la retinopatía diabética. | |
| SE0401631L (sv) | Ny sammansättning | |
| WO2007058639A3 (en) | Antibacterial agents | |
| AR040287A1 (es) | Plataforma para formulaciones transdermicas (pft) | |
| NO20024673L (no) | Farmasöytisk sammensetning med kontrollert frigivning for oral anvendelse inneholdende midodrin og/eller desglymidodrin | |
| MXPA05006408A (es) | Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos. | |
| TW200618812A (en) | Compositions containing piperacillin and tazobactam useful for injection | |
| MX2008015323A (es) | Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion. | |
| US20040204493A1 (en) | Carbonic anhydrase inhibitors as drugs to eradicate Helicobacter pylori in the mammalian, including human, stomach |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |